Cloudflare Hosting

Gravity Forms

Business Management

Jack Reich

President

Roy Cosan

CEO at MediLite Diagnostika, Inc. And Owner, MediLite Diagnostika, Inc

Vijay Mahant

President and CEO

Senior Vice President, Finance and Business Operations

Catherine Bovenizer

Vice President

Peter Gengo

CEO, President

CEO and President

Kirk Hammond

Founder

Biotechnology Late Stage Companies With More Than 10 Employees

Biotechnology Late Stage Companies With Less Than $500M in Revenue

Western US Late Stage Companies With Less Than $50M in Revenue

Western US Late Stage Companies With Less Than $500M in Revenue

Renova Therapeutics provides gene therapy pursuing the development of treatments for congestive heart failure and chronic diseases. They enable the generation of an original platform of therapeutics and delivery systems that in a  dose may provide treatments for chronic diseases including congestive heart failure and diabetes. Their investigational gene therapies are based on validated and proprietary research into disease mechanisms.

Series D - Renova Therapeutics

Series C - Renova Therapeutics

Carlsbad

California

United States

North America

Renova Therapeutics

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and ...

Renova Therapeutics Announces Potential Expansion of Gene...

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart ...

Renova Therapeutics Announces Strategic Focus and Roadmap...

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus

Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes

Renova Therapeutics: JACC: Basic to Translational Science publishes article comparing effects of urocortin 2 versus urocortin 3 gene transfer on left ventricular function and glucose disposal

HTML5

Google Analytics

jQuery

Microsoft Outlook

Vimeo

GoDaddy Premium DNS

F5 NGINX

Wordpress

Cloudflare CDN

Google Tag Manager

Renova Therapeutics is a biotechnology research company focused on developing definitive gene and peptide therapies to restore health to people suffering from cardiovascular and metabolic diseases. Their investigational therapies are based on carefully validated and proprietary research into disease mechanisms and the founders’ nearly 50 combined years of work in the gene therapy field.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 4:33 PM	387768dc
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 4:33 PM	f495abdf
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	73d7f9f0
crunchbase profile	general	Oct 28, 2024 1:58 PM	7d12a543
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	98c22e97
peers	general
news basic	general	Mar 8, 2024 4:33 PM	3a45c763
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

RENO

COM:RENOVATHERAPEUTICS

Renova Therapeutics